News

FDA panel promotes misinformation about antidepressants during pregnancy
NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...
Green Matters46m
Popular Deodorant Brand Recalls Over 67,000 Cases of Antiperspirant for Failing To Reach Quality and Safety Standards
The FDA is sounding the alarm with a deodorant recall that is impacting more than 67,000 cases of antiperspirant made by a ...
India Today53m
Children's Hospital LA halts use of Sarepta's gene therapy for all patients
Children’s Hospital Los Angeles paused Sarepta’s Elevidys gene therapy after FDA flagged safety issues, including deaths in ...